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Arsenic is a highly potent toxicant and car-
cinogen [International Agency for Research 
on Cancer 2004; National Research Council 
(NRC) 2001]. Worldwide, millions of indi-
viduals are drinking well water with arsenic 
levels above the World Health Organization 
(WHO) guidel ine value of  10 µg/L 
(Kinniburg 2001; Nordstrom 2002; WHO 
2004). Arsenic concentrations are high in 
certain geologic formations, and arsenic can 
dissolve easily to groundwater and contami-
nate local tube wells and other public water 
supplies. This has been a problem in many 
parts of the world, including Argentina, 
Bangladesh, Chile, China, Hungary, India, 
Taiwan, and parts of the United States 
(Chowdhury et al. 2000; Nordstrom 2002; 
Smith 2000). Arsenic exposure is associated 
with several severe health consequences, such 
as cancers, chronic diseases, and possibly with 
negative reproductive outcomes (NRC 2001).
An ecologic study in Chile reported 
increased neonatal and postneonatal mortal-
ity in an area with high arsenic content in 
the public water supply (Hopenhayn-Rich 
et al. 2000). In a retrospective cohort of about 
29,000 women in Bangladesh, we found 
a significant dose-dependent association 
between infant mortality and arsenic exposure 
measured in tube-well water used by pregnant 
women (Rahman et al. 2007). The association 
was more pronounced when the outcome was 
restricted to infectious disease deaths. We also 
observed a significant increase risk of infant 
mortality in association with urinary arsenic 
concentrations during pregnancy in a pro-
spective cohort study conducted in the same 
area (Rahman et al. 2010).
Arsenic-related infant mortality may, in 
part, be mediated via infectious diseases. A 
few animal and human studies have indicated 
that arsenic is associated with immunosup-
pression. In experimental studies, arsenic 
exposure suppressed the immunoglobulin (Ig) 
M and IgG antibody–forming cell response 
(Selgrade 2007), decreased interleukin-2 
mRNA expression (Conde et al. 2007), and 
inhibited antigen-driven T-cell prolifera-
tion and macrophage activity and suppressed 
contact hypersensitivity responses (Patterson 
et al. 2004). Further, inorganic arsenic was 
found to impair the function of human mac-
rophages both in vivo and in vitro (Banerjee 
et al. 2009; Lemarie et al. 2006). In a study 
in Mexico, an increased concentration of 
arsenic in urine was associated with reduced 
proliferative response to phytohemagglutinin 
stimulation, CD4+ subpopulation proportion, 
and interleukin-2 secretion levels in children 
(Soto-Pena et al. 2006). We recently reported 
an association between arsenic exposures 
through drinking water during pregnancy 
in rural Bangladesh and reduced placental 
T cells and altered cord blood cytokines, indi-
cating effects of arsenic on immune function 
(Ahmed et al. 2011). These immunologic 
effects may potentially contribute to a high 
burden of infectious diseases in childhood.
Lower respiratory tract infection (LRTI) 
and diarrhea are two of the most common 
causes of morbidity and mortality in children 
< 5 years of age, especially in low-income 
countries. So far, very little is known about 
the influence of arsenic exposure on these 
morbidities. The objective of this prospective 
cohort study was to evaluate the association 
between prenatal arsenic exposure and LRTI 
and diarrhea during infancy in Bangladesh.
Methods
Study site. The study was conducted at Matlab, 
a subdistrict of Chandpur, Bangladesh, where 
arsenic contamination in tube-well water is 
common (Rahman et al. 2006). At the study 
site, the International Centre for Diarrhoeal 
Disease Research, Bangladesh (ICDDR,B), 
has been running a health and demographic 
surveillance system (HDSS) since 1966 in a 
population of 220,000. The HDSS area is 
divided into two parts: the ICDDR,B service 
area, where ICDDR,B provides services to all 
women of reproductive age and their children 
< 5 years of age; and the government service 
area, where health services are provided at 
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Background: Previous studies have reported associations between prenatal arsenic exposure and 
increased risk of infant mortality. An increase in infectious diseases has been proposed as the under-
lying cause of these associations, but there is no epidemiologic research to support the hypothesis. 
oBjective: We evaluated the association between arsenic exposure in pregnancy and morbidity 
during infancy.
Methods: This prospective population-based cohort study included 1,552 live-born infants of 
women enrolled during 2002–2004 in Matlab, Bangladesh. Arsenic exposure was assessed by the 
concentrations of metabolites of inorganic arsenic in maternal urine samples collected at gestational 
weeks 8 and 30. Information on symptoms of lower respiratory tract infection (LRTI) and diarrhea 
in infants was collected by 7-day recalls at monthly home visits.
results: In total, 115,850 person-days of observation were contributed by the infants during 
a 12-month follow-up period. The estimated risk of LRTI and severe LRTI increased by 69% 
[adjusted relative risk (RR) = 1.69; 95% confidence interval (CI), 1.36–2.09)] and 54% (RR = 1.54; 
95% CI, 1.21–1.97), respectively, for infants of mothers with urinary arsenic concentrations in the 
highest quintile (average of arsenic concentrations measured in early and late gestation, 262–977 
µg/L) relative to those with exposure in the lowest quintile (< 39 µg/L). The corresponding figure 
for diarrhea was 20% (RR = 1.20; 95% CI, 1.01–1.43).
conclusions: Arsenic exposure during pregnancy was associated with increased morbidity in 
infectious diseases during infancy. Taken together with the previous evidence of adverse effects on 
health, the findings strongly emphasize the need to reduce arsenic exposure via drinking water.
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government facilities. The ICDDR,B service 
area comprises four administrative blocks that 
each has a subcenter where paramedical staff 
provide 24-hr maternal and child health care. 
All subcenters are linked to a hospital, located 
at Matlab Township. Community health 
research workers (CHRWs), employed by the 
HDSS, collect information on vital events such 
as marriage, birth, death, and migration during 
monthly household visits with area residents.
Study design and participants. This pro-
spective cohort study was embedded into a 
food and micronutrient supplementation trial: 
Maternal and Infant Nutrition Interventions, 
Matlab (MINIMat trial, ISRCTN 16581394). 
The study was based on a cohort of live-born 
infants of pregnant women who were enrolled 
in the MINIMat study from February 2002 to 
January 2003, and data collection in the field 
continued until the end of 2004. Enrollment 
in the MINIMat study has been described 
elsewhere (Rahman et al. 2009). In short, dur-
ing monthly home visits CHRWs performed 
urine pregnancy tests for women who reported 
that their menstrual period was > 2 weeks late. 
Women with a positive pregnancy test were 
invited to donate the remaining urine sample, 
which was usually collected at or around ges-
tational week (GW) 8 for arsenic analysis. All 
women with a positive pregnancy test were 
advised to visit their health clinic for further 
evaluation of eligibility for the MINIMat 
study: a viable fetus < GW13 as detected by 
ultrasound examination, no severe illness, and 
consent for participation. On enrollment, 
usually around GW9, pregnant women were 
randomly assigned to receive an early invita-
tion to begin food supplementation (started 
in the first trimester) or an invitation at the 
usual time (started in the second trimester). 
Women in each group were further random-
ized into three micronutrient supplementation 
groups: a) 30 mg iron and 400 µg folic acid, 
b) 60 mg iron and 400 µg folic acid, or c) the 
United Nations Children’s Fund/United 
Nations University/WHO preparation of 
15 different micronutrients, including 30 mg 
iron and 400 µg folic acid. Food supplementa-
tion continued until the pregnancy was com-
pleted; micronutrient supplementation was 
continued until 6 weeks postpartum. For the 
present study, an additional urine sample was 
collected from all enrolled women during a 
routine clinic visit late in gestation, usually at 
or around GW30.
Mother–infant pairs were included in 
the present analysis if they had at least one 
postnatal monthly visit (to collect morbid-
ity information) and had measured maternal 
urinary arsenic concentrations at early and late 
gestation. Of 2,281 women enrolled in the 
MINIMat study between February 2002 and 
January 2003, 1,552 were available for analy-
sis. In total, 729 women were not available 
for evaluation because of abortion (n = 164), 
stillbirth (n = 42), loss to follow-up (including 
outmigration; n = 361), and no urine arse-
nic concentration measurement at GW8 or 
GW30 (n = 162). Because each mother–infant 
pair was followed up every month in infancy, 
and each visit included a 7-day morbidity 
recall, an infant could contribute up to 84 
days to the study base. The mean number of 
person-days of observation was 75. In total, 
115,850 person-days of observation were con-
tributed by 1,552 infants.
Exposure assessment. Individual exposure 
was assessed based on urinary concentration 
of the sum of inorganic arsenic and the meth-
ylated metabolites, methylarsonic acid, and 
dimethylarsinic acid (DMA), in early and late 
gestational periods. Individual exposure was 
also assessed by average of the two urinary 
arsenic concentrations (in early and late gesta-
tion). Details concerning sample collection 
and transport have been described elsewhere 
(Vahter et al. 2006). In brief, CHRWs col-
lected GW8 urine samples during monthly 
home visits. The samples were chilled imme-
diately with cooling blocks and transported 
to Matlab Hospital laboratory, where the 
samples were stored at –70°C. GW30 urine 
samples were collected during antenatal visits 
to the subcenters. These samples were initially 
stored at –20°C until end of the day, when 
they were transported to Matlab Hospital and 
stored at –70°C. Batches of samples were then 
transported frozen to Karolinska Institutet 
(Stockholm, Sweden), where they were ana-
lyzed using hydride generation atomic absorp-
tion spectroscopy (Vahter et al. 2006). The 
detection limit was 1.3 ± 0.27 µg/L. A couple 
of urine samples that contained arsenic con-
centrations close to the detection limit were 
reanalyzed using a larger volume; thus, no 
samples had arsenic concentrations below the 
detection limit. Longitudinal quality con-
trol showed good analytical quality (Vahter 
et al. 2006). Urinary arsenic concentrations 
were adjusted by specific gravity (average, 
1.012 g/mL) to account for differences in 
urine dilution due to variation in fluid intake, 
time of sampling, temperature, and physical 
activity (Nermell et al. 2008). The concen-
tration of metabolites of inorganic arsenic 
in urine is a recognized biomarker of the 
exposure to inorganic arsenic (Vahter 2002). 
Additional exposure to DMA or to organic 
arsenic metabolized in the body to DMA, 
which usually is attributable to consumption 
of seafood such as bivalves and seaweeds, was 
considered minimal because such seafoods are 
essentially never eaten in this area.
Outcomes. A birth notification system 
was developed for the MINIMat study, and 
 mother–infant pairs were followed up by 
monthly home visits. Information on symp-
toms related to LRTI and diarrhea, the two 
most common morbidities during infancy, 
was collected by repeated 7-day recalls. 
Mothers were asked about cough and/or dif-
ficult breathing in their infants in the preced-
ing 7 days. If a woman’s answer was positive, 
she was further asked about the presence of 
rapid respiration and chest in-drawing (reces-
sion of subcostal margin during inspiration). 
The mother was also asked about passage of 
loose or watery stools, including frequency or 
passage of stool with blood. LRTI was defined 
as cough and/or difficult breathing combined 
with rapid respiration. Severe LRTI was 
defined as symptoms of LRTI accompanied 
by chest in-drawing. Diarrhea was defined as 
three or more liquid stools in 24 hr or stools 
mixed with blood.
Covariates. At enrollment in the MINIMat 
study, information on women’s age, parity, 
education, and socioeconomic status was col-
lected. Education was expressed as number of 
completed years in formal school. Parity was 
defined as the number of previous live births. 
Economic status was assessed by generating 
scores through principal component analysis 
based on household assets, housing structure, 
land occupation, and income. The generated 
scores were thereafter indexed into quintiles, 
where 1 represents the poorest and 5 the rich-
est (Gwatkin et al. 2000). Last menstrual 
period was determined by recall at the time 
the pregnancy test conducted. Gestational age 
was calculated by subtracting last menstrual 
period date from the date of birth of infants 
and was expressed in weeks.
Women’s weight and height were meas-
ured at the first clinic visit during pregnancy 
around GW9. Weight was measured by elec-
tronic scales (model UNISCALE; SECA, 
Hamburg, Germany; precision of 100 g), 
and height was measured with a locally made 
wooden scale (precision of 0.1 cm). Body mass 
index (BMI), used as a measure of the nutri-
tional status of the women, was calculated as 
weight divided by height squared (kilograms 
per square meter).
The birth notification system enabled 
measurement of birth anthropometry within 
72 hr. Data on sex of the child and birth 
weight were collected. Birth weight was meas-
ured by beam scales (model 770; SECA) with 
a precision of 10 g.
Statistical analysis. Incidence rates with 
95% confidence intervals (CIs) were esti-
mated for LRTI and diarrhea morbidity in the 
infant population as a whole. Median urinary 
arsenic concentrations (micrograms per liter) 
were estimated according to the background 
characteristics, and p-values for associations 
were estimated by median test. Associations 
between outcomes and background character-
istics were also assessed, and p-values for asso-
ciations were estimated by the chi-square test. 
Statistical associations were determined based 
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on p < 0.05 significance level. Relative risks 
(RRs) of LRTI, severe LRTI, and diarrhea in 
relation to average prenatal arsenic exposure 
(mean arsenic concentrations of early and late 
gestation) were evaluated by Poisson regres-
sion, with arsenic exposure divided into quin-
tiles and the first quintile used as the reference 
group. We also estimated associations with 
early and late exposures separately based on 
measurements of samples taken during early 
and late pregnancy. We assessed the dose–
response relationship of arsenic exposure (by 
quintile of arsenic exposure as an ordinal vari-
able) with risk of morbidity.
In addition, we performed stratified analy-
ses on important social and biological strata to 
evaluate the robustness of the findings in the 
different models. We tested for presence of 
effect modification by making an interaction 
term (exposure × independent variable) and 
entering the term along with exposure and 
variable of interest in the model.
We identified potential confounders 
on the basis of associations with both the 
exposure and outcome at p < 0.20 and were 
included in the multivariate model if they 
changed the RR for arsenic by ≥ 5% or were 
associated with outcomes with p < 0.10.
Ethical consideration. The MINIMat 
study obtained informed written consent 
from mothers for participation in the study 
for themselves and also for their infants. 
Because of the long time period between the 
collection of urine samples and laboratory 
analysis, we were not able to inform partici-
pants about their individual arsenic exposure. 
However, a separate project was initiated in 
parallel that assessed arsenic concentrations in 
water from all tube wells in the area and used 
red paint to identify unsafe tube wells with 
arsenic concentrations above the local drink-
ing water standard of 50 µg/L (Rahman et al. 
2006). In addition, different options for safe 
water sources were discussed during a series 
of community meetings conducted as part 
of the mitigation activities. This study was 
approved by the ethical review committees of 
ICDDR,B and Karolinska Institutet.
Results
The mean (± SD) age of the women included 
in the analysis was 27 ± 6 years at enrollment. 
About one-third of the women were nullipa-
rous, and one-fourth had not completed even 
1 year at school. The mean body weight and 
height of women at GW8 were 45.0 ± 6.6 kg 
and 149.6 ± 5.2 cm, respectively, and about 
one-third of women were malnourished (BMI 
< 18.5 kg/m2). The mean duration of preg-
nancy was 39 ± 2 weeks. About 12% of the 
infants were born preterm (< 37 weeks). The 
mean birth weight of infants was 2,688 ± 398 
g, and 52% were male. In this cohort, women 
did not smoke cigarettes or consume alcohol.
Table 1 presents the concentrations of 
arsenic in urine at GW8 and GW30 and the 
average of those two measures. We found 
wide variations of arsenic concentrations in 
maternal urine. The urinary arsenic concentra-
tions at GW8 and GW30 were significantly 
correlated (Spearman’s r = 0.61; p ≤ 0.001).
The incidence rates of LRTI and severe 
LRTI in the infants during their first year of life 
were 2.96 (95% CI, 2.78–3.16) and 2.35 (95% 
CI, 2.18–2.52) episodes/person-year, respec-
tively. The incidence of diarrhea was 4.01 (95% 
CI, 3.80–4.24) episodes/person-year.
Mothers’ education, socioeconomic status 
by asset index, and BMI were associated with 
urinary arsenic concentrations. Maternal par-
ity, education, asset index, and gestational age 
at birth were associated with both LRTI and 
diarrhea morbidities (Table 2). BMI and sex of 
infant were associated with LRTI only, whereas 
maternal age was associated with diarrhea only 
(Table 2). The randomized food and micronu-
trient treatment groups of the MINIMat trial 
were not associated with arsenic exposure levels 
(p = 0.638 by Kruskal–Wallis test).
Arsenic exposure was significantly asso-
ciated with the risk of LRTI and diarrhea 
(Table 3). Compared with exposure to average 
urinary arsenic at the first quintile level, the 
Table 1. Concentration of urinary arsenic in early 
and late gestational periods (GW8 and GW30) 
among the 2002–2003 pregnancy cohort in Matlab, 
Bangladesh.
Urinary arsenic 
concentration (µg/L)a
Average of 
GW8 and 
GW30bStatistic GW8 GW30
Mean ± SD 152 ± 175 166 ± 196 159 ± 163
Median 79 80 94
25th percentile 36 41 43
75th percentile 210 225 220
Lowest 1 2 6
Highest 1,211 1,440 977
aSum of inorganic and methylated arsenic species. 
bMean of the two urinary arsenic concentrations (in 
early and late gestation).
Table 2. Background characteristics and their associations with mothers’ urinary arsenic concentrations 
and reported symptoms of LRTI and diarrhea among the infants of the 2002–2003 pregnancy cohort in 
Matlab, Bangladesh.
Arsenic level
LRTI DiarrheaMedian 
(µg/L)aCharacteristic n (%) p-Value RR (95% CI) p-Value RR (95% CI) p-Value
Age (years)
< 20b 182 (11.7) 118 0.263 1 1
20–24 442 (28.9) 96 0.81 (0.65–1.01) 0.059 1.15 (0.94 –1.41) 0.174
25–34 744 (47.9) 92 0.99 (0.81–1.21) 0.954 1.26 (1.04–1.52) 0.019
≥ 35 184 (11.9) 80 1.01 (0.78–1.30) 0.936 1.35 (1.07–1.70) 0.010
Parity
0b 502 (32.4) 91 0.572 1 1
1 399 (25.7) 93 1.13 (0.94–1.35) 0.186 1.15 (0.99–1.33) 0.066
2–3 330 (21.3) 100 1.36 (1.14–1.62) 0.001 1.17 (1.00–1.36) 0.051
≥ 4 320 (20.6) 101 1.40 (1.17–1.67) < 0.001 1.29 (1.11–1.50) 0.001
Education (years)
0b 390 (25.1) 107 0.001 1 1
1–5 479 (30.9) 103 0.85 (0.72–1.00) 0.050 1.01 (0.88–1.17) 0.832
> 5 683 (44.0) 83 0.72 (0.62–0.85) < 0.001 0.83 (0.72–0.95) 0.008
Asset index
1 (poorest)b 344 (22.2) 124 < 0.001 1 1
2 328 (21.1) 103 0.76 (0.64–0.91) 0.002 0.79 (0.67–0.93) 0.004
3 284 (18.3) 104 0.67 (0.55–0.81) < 0.001 0.73 (0.62–0.87) < 0.001
4 284 (18.3) 84 0.54 (0.44–0.66) < 0.001 0.71 (0.60–0.84) < 0.001
5 (richest) 312 (20.1) 65 0.46 (0.37–0.57) < 0.001 0.69 (0.59–0.82) < 0.001
Height (m)
< 1.50b 787 (50.7) 95 0.847 1 1
≥ 1.50 765 (49.3) 94 1.06 (0.94–1.21) 0.342 1.03 (0.93–1.15) 0.540
BMI (kg/m2)
< 18.5b 464 (30.0) 110 0.026 1 1
18.5–24 1,005 (64.5) 91 0.87 (0.76–1.00) 0.057 0.95 (0.85–1.08) 0.444
≥ 25 79 (5.1) 75 0.62 (0.43–0.88) 0.008 1.03 (0.79–1.33) 0.838
Birth weight of infant (g)
< 2,000b 58 (3.7) 92 0.588 1 1
2,000–2,499 421 (27.1) 88 0.86 (0.61–1.22) 0.405 0.99 (0.73–1.35) 0.955
≥ 2,500 1,072 (69.1) 98 0.85 (0.61–1.18) 0.328 0.95 (0.71–1.28) 0.727
Gestational age at birth (weeks)
< 37b 181 (11.7) 103 0.295 1 1
≥ 37 1,371 (88.3) 93 0.83 (0.67–0.98) 0.030 0.83 (0.71–0.98) 0.028
Sex of infant
Maleb 804 (51.8) 92 0.534 1 1
Female 748 (48.2) 97 0.83 (0.73–0.94) 0.004 0.93 (0.83–1.04) 0.212
aMean urinary arsenic concentrations in early and late gestation; sum of inorganic and methylated arsenic species. 
bReference group.
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risk of LRTI and severe LRTI was increased 
by 69% (RR 1.69; 95% CI, 1.36–2.09) 
and 54% (RR = 1.54; 95% CI, 1.21–1.97), 
respectively, for women who had urinary arse-
nic concentrations at the fifth quintile level. 
The corresponding increase for diarrhea was 
20% (RR = 1.20; 95% CI, 1.01–1.43). We 
also observed dose-dependent associations of 
arsenic exposures with both LRTI and severe 
LRTI across quintiles of arsenic concentra-
tions at GW8, GW30, and the average arsenic 
concentrations (test for linear-trend p < 0.05). 
We observed a dose-dependent association of 
risk of diarrhea with arsenic concentration at 
GW8 and the average concentrations, but not 
with arsenic concentrations at GW30 (test for 
linear-trend p > 0.05).
Comparison of the impact of arsenic 
exposure in early and late gestation on mor-
bidity showed that the risk for LRTI was 
more pronounced if the exposure was based 
on urinary arsenic concentration in late gesta-
tion, whereas the risk for diarrhea was more 
pronounced if exposure was based on urinary 
arsenic at early gestational (Table 3).
In the stratified analyses (by infant age, 
maternal education, socioeconomic status by 
asset index, and maternal BMI), we observed a 
significant risk increase for LRTI in all strata. 
However, the arsenic-related risk increase was 
more pronounced for infants of mothers with 
no formal education and low socioeconomic 
condition (Table 4). We observed no effect 
modification of arsenic exposure by these 
variables when tested in the model with inter-
action term (p > 0.10) (data not shown).
Discussion
To our knowledge, this is the first prospective 
cohort study evaluating the association between 
prenatal arsenic exposure and the occurrence of 
LRTI and diarrhea, two of the most common 
causes of severe morbidity and mortality dur-
ing infancy in low-income countries. These 
two conditions have been estimated to cause 
50% of deaths among children < 5 years of 
age (Rudan et al. 2007). We observed a dose-
dependent increased risk of LRTI and diarrhea 
in relation to prenatal arsenic exposure. Given 
that background and the magnitude of arsenic 
exposure in Bangladesh, our findings are of 
important public health significance.
In this community-based prospective 
study, the strengths were a relatively large sam-
ple size, objective measures of individual expo-
sure based on urinary arsenic concentrations 
twice during pregnancy, prospectively col-
lected outcome data, and availability of data 
on important covariates to adjust for possible 
confounding. Data were also collected over an 
entire calendar year, which would reduce any 
influence by seasons. We minimized meas-
urement errors through the use of standard-
ized protocols to maintain the quality of urine 
samples from collection to laboratory analyses. 
Potential limitations include outcome clas-
sification based on mothers’ reports of symp-
toms and signs, lack of measurements of infant 
exposure to arsenic, and a lack of information 
about other potentially toxic substances in 
water and food.
The measured urinary arsenic concentra-
tions reflect exposure to inorganic arsenic from 
all sources of water, as well as from food dur-
ing pregnancy. The analytical method used 
in the analysis, hydride generation atomic 
absorption spectroscopy, is specific for the sum 
of inorganic arsenic and its metabolites. Earlier 
studies have shown that very small amounts 
of arsenic pass to breast milk (Concha et al. 
1998; Fangstrom et al. 2008). In the same 
study area as this study, arsenic levels in urine 
samples collected in infants at 3 months of 
age were very low (median, 1 µg/L) compared 
Table 3. RRs for episodes of LRTI and diarrhea among the infants in relation to maternal arsenic exposure in pregnancy: 2002–2003 pregnancy cohort in Matlab, 
Bangladesh.
Arsenic levels 
in quintiles 
(µg/L)a
LRTI Severe LRTI Diarrhea
Person-weeks 
of recall
No. of 
episodes RR (95% CI)
Adjusted RR 
(95% CI)b
No. of 
episodes RR (95% CI)
Adjusted RR 
(95% CI)b
No. of 
episodes RR (95% CI)
Adjusted RR 
(95% CI)b 
Averagec
< 39d 3,380 134 1 107 1 238 1 1
39–64 3,394 172 1.28 (1.02–1.60) 1.28 (1.02–1.61) 143 1.33 (1.04–1.71) 1.33 (1.03–1.71) 236 0.99 (0.082–1.18) 0.99 (0.83–1.19)
65–132 3,309 185 1.41 (1.13–1.76) 1.33 (1.07–1.67) 148 1.41 (1.10–1.81) 1.31 (1.02–1.69) 230 0.99 (0.82–1.18) 0.96 (0.80–1.15)
133–261 3,198 215 1.69 (1.37–2.10) 1.57 (1.27–1.96) 173 1.71 (1.34–2.17) 1.54 (1.21–1.97) 291 1.29 (1.09–1.53) 1.25 (1.05–1.48)
≥ 261 3,269 237 1.83 (1.48–2.26) 1.69 (1.36–2.09) 177 1.71 (1.34–2.17) 1.54 (1.21–1.97) 283 1.23 (1.03–1.46) 1.20 (1.01–1.43)
GW8
< 32d 3,373 155 1 1 120 1 1 210 1 1
32–56 3,407 167 1.07 (0.86–1.33) 1.08 (0.86–1.34) 141 1.16 (0.91–1.49) 1.16 (0.91–1.49) 254 1.20 (1.00–1.44) 1.20 (1.00–1.44)
57–116 3,335 179 1.17 (0.94–1.45) 1.12 (0.90–1.39) 144 1.21 (0.95–1.55) 1.14 (0.89–1.45) 252 1.21 (1.01–1.46) 1.19 (0.99–1.43)
117–247 3,152 220 1.52 (1.24–1.86) 1.43 (1.17–1.77) 169 1.51 (1.19–1.90) 1.39 (1.10–1.76) 268 1.36 (1.14–1.63) 1.33 (1.11–1.60)
≥ 248 3,280 222 1.47 (1.20–1.81) 1.37 (1.11–1.68) 174 1.49 (1.18–1.88) 1.34 (1.06–1.70) 294 1.44 (1.20–1.72) 1.40 (1.17–1.68)
GW30
< 36d 3,464 139 1 115 1 242 1 1
36–61 3,290 184 1.39 (1.12–1.74) 1.33 (1.06–1.66) 159 1.45 (1.14–1.85) 1.37 (1.08–1.74) 259 1.12 (0.94–1.34) 1.12 (0.94–1.33)
62–114 3,378 184 1.36 (1.09–1.69) 1.30 (1.04–1.62) 134 1.19 (0.93–1.53) 1.13 (0.88–1.45) 237 1.00 (0.84–1.20) 0.99 (0.83–1.19)
115–268 3,249 193 1.48 (1.19–1.84) 1.38 (1.11–1.72) 161 1.49 (1.17–1.90) 1.35 (1.06–1.72) 261 1.15 (0.96–1.37) 1.11 (0.93–1.32)
≥ 269 3,169 243 1.91 (1.55–2.35) 1.74 (1.41–2.14) 179 1.70 (1.34–2.15) 1.50 (1.18–1.90) 279 1.27 (1.06–1.50) 1.21 (1.02–1.44)
aSum of inorganic and methylated arsenic species. bTest for linear trend p < 0.05 for all exposures levels (GW8, GW30, and average) except diarrhea for GW30, adjusted for mother’s 
education, asset index, parity, BMI, gestational age, and infant’s sex. cMean urinary arsenic concentrations at GW8 and GW30. dReference group. 
Table 4. RR (95% CI) of LRTI in relation to maternal arsenic exposure in pregnancy (mean of urinary arsenic measures at GW8 and GW30) stratified by infants’ 
age, mothers’ education level, socioeconomic status, and BMI in the in 2002–2003 pregnancy cohort in Matlab, Bangladesh.
Infant’s ageb Educationb Socioeconomic statusb,c BMI (kg/m2)b
Arsenic levela 0–5 months 6–11 months No schooling Attended school Low High < 18.5 ≥ 18.5
< 39d 1 1 1 1 1 1 1 1
39–64 1.11 (0.81–1.51) 1.47 (1.05–2.05) 2.68 (1.65–4.35) 0.97 (0.75–1.27) 1.83 (1.28–2.62) 0.85 (0.58–1.25) 1.38 (0.91–2.10) 1.22 (0.93–1.60)
65–132 1.23 (0.90–1.66) 1.48 (1.06–2.07) 2.74 (1.64–4.655) 1.08 (0.94–1.38) 1.79 (1.26–2.55) 1.08 (0.73–1.58) 1.19 (0.78–1.81) 1.41 (1.08–1.83)
133–261 1.31 (0.97– 1.78) 1.89 (1.38–2.60) 3.28 (2.04–5.27) 1.20 (0.93–1.55) 2.42 (1.73–3.37) 1.23 (0.85–1.80) 1.73 (1.17–2.56) 1.51 (1.16–1.96)
262–977 1.57 (1.18–2.10) 1.81 (1.32–2.49) 2.41 (1.48–3.92 1.53 (1.20–1.94) 2.25 (1.61–3.14) 1.57 (1.09–2.26) 1.92 (1.31–2.80) 1.54 (1.19–2.01)
aSum of inorganic and methylated arsenic species. bAdjusted for all the variables in the table except the one used for stratification. cSocioeconomic status: low, asset index 1 or 2; 
high, asset index 4 or 5. dReference group.
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with maternal concentrations (Fangstrom 
et al. 2008), particularly among infants who 
were exclusively breast-fed. About 50% of the 
infants of the MINIMat cohort were exclu-
sively breast-fed for 4–6 months (Eneroth et al. 
2009) and partially breast-fed for > 2 years 
(Saha et al. 2008). Therefore, we assume that 
the observed associations with morbidity in 
infancy probably were consequences of in utero 
exposure to arsenic, possibly in combination 
with maternal toxicity during pregnancy, with 
indirect effects on the fetus.
Identifying cases based on reported symp-
toms through regular home visits is a com-
mon way of collecting information on acute 
respiratory tract infection (ARI) and diarrhea 
in epidemiologic studies and demographic 
and health surveys in developing countries, 
where most cases are not reported to health 
facilities (Feikin et al. 2010). ICDDR,B initi-
ated an ARI surveillance in 1988, and case 
identification was carried out by active surveil-
lance with biweekly home visits of CHRWs 
for initial 2 years (Fauveau et al. 1992) and 
thereafter by passive surveillance. Therefore, 
the knowledge of key symptoms of ARI may 
be relatively high among the study population. 
Further, including fast breathing and chest 
in-drawing as signs of LRTIs increases the 
positive predictive value of the screening ques-
tions (Lanata et al. 2004). Health surveillance 
in the study area has also focused on diarrheal 
diseases, so the mothers were likely to cor-
rectly report symptoms and signs of diarrhea 
as well. Even if there are errors in self-reported 
symptoms of these disease groups, there is no 
reason to believe that such misclassifications 
would be differential in relation to arsenic 
exposure levels.
Some previous studies have reported respi-
ratory symptoms and signs such as chronic 
cough, bronchitis, and bronchiectasis, in rela-
tion to drinking water with high arsenic levels 
(Islam et al. 2007; Mazumder et al. 2005; 
Milton and Rahman 2002). In a review 
paper on the burden of pneumonia, the rate 
of pneumonia was reported 0.1–1.2 epi-
sodes/person-year among children < 5 years 
of age (Singh 2005). The rate in our study 
is higher than that, which may be attribut-
able to the age range of infancy in our study 
and/or the widespread exposure to arsenic in 
the study population. Another report from 
rural Bangladesh showed an incidence rate 
of diarrhea of 4.25 episodes per child-year, 
which is similar to the rate we observed in our 
study (Pathela et al. 2006).
A possible causal pathway for an effect of 
arsenic exposure on incidence of LRTI and 
diarrhea is through immunosuppression, as 
suggested by several studies mentioned above 
(Banerjee et al. 2009; Conde et al. 2007; 
Lemarie et al. 2006; Patterson et al. 2004; 
Selgrade 2007). Indeed, in a subset of mothers 
in this cohort, we found that arsenic exposure 
in pregnancy, particularly in early pregnancy, 
was associated with fewer T cells (CD3+ cells) 
in the placenta (Ahmed et al. 2011). Arsenic 
induces reactive oxygen species, as also observed 
in mothers of the present cohort (Ahmed et al. 
2011; Engström et al. 2010), and oxidative 
stress is known to affect the immune system 
(Knight 2000; NRC 2001). In another study 
in our cohort of women, we observed an asso-
ciation between prenatal arsenic exposure and 
decreased thymus size in the offspring (Moore 
et al. 2009), as well as secretion of trophic fac-
tors such as lactoferrin and interleukin-7 in 
breast milk (Raqib et al. 2009).
From a public health point of view, the 
observed increased risks of LRTI and diar-
rhea morbidity are noticeable, considering 
the effect sizes and extent of arsenic expo-
sure worldwide. For example, an RR of 1.69 
for LRTI with high arsenic exposure and an 
incidence rate of 2.96 LRTI episodes/person-
year indicated about 2 additional episodes/
person-year among the highly exposed relative 
to those with low exposure. An RR of 1.20 
for diarrhea with high arsenic exposure and 
an incidence rate of 4.01 diarrhea episodes/
person-year indicated < 1 additional episode/
person-year among the highly exposed relative 
to those with low exposure.
We observed significant risk increase of 
LRTI and diarrhea morbidity irrespective of 
sociodemographic factors or nutritional status 
of the women. However, further evaluation 
is needed in a larger sample to evaluate the 
possible effect modification, because the RRs 
seemed to be more pronounced in low social 
strata. The possibility of residual confounding 
in our analyses cannot be completely ruled 
out, but we believe it is low given adjustment 
for potential confounding by relevant cova-
riates. Measurement of arsenic exposure in 
early childhood is required in future studies 
to evaluate the association between arsenic 
exposure and morbidity in older children.
Conclusions
We have shown that prenatal arsenic expo-
sure was associated with increased risk of 
LRTI and diarrhea morbidity of the offspring 
during infancy. Taken together with ear-
lier reports of effects on health, the findings 
strongly emphasize the need for a lowering of 
arsenic exposure via drinking water.
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